Table 3 Result of base-case analysis.

From: Comparative study of safflower yellow adjuvant to conventional treatment regimen and conventional treatment regimen on diabetic nephropathy

Treatment

Cost (yuan)

Effectiveness

Incremental cost (yuan)

Incremental effectiveness

ICER

CT

10,318.79

0.7106

–

–

–

SY adjuvant to CT

11,459.59

0.9124

1140.80

0.2018

5653.12

  1. CT, conventional treatment; SY, safflower yellow; ICER, incremental cost-effectiveness ratio.
Back to article page